Singular Genomics Systems Inc (OMIC)
15.49
-0.02
(-0.13%)
USD |
NASDAQ |
Sep 27, 16:00
15.60
+0.11
(+0.71%)
After-Hours: 20:00
Singular Genomics Systems SG&A Expense (Annual): 54.48M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 54.48M |
| December 31, 2022 | 47.26M |
| December 31, 2021 | 28.62M |
| Date | Value |
|---|---|
| December 31, 2020 | 6.287M |
| December 31, 2019 | 2.286M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
2.286M
Minimum
2019
54.48M
Maximum
2023
27.79M
Average
28.62M
Median
2021
SG&A Expense (Annual) Benchmarks
| Bruker Corp | 730.10M |
| Azenta Inc | 316.28M |
| Harvard Bioscience Inc | 46.89M |
| Bionano Genomics Inc | 93.50M |
| Akoya Biosciences Inc | 82.38M |